Skip to main content

Ischemic Heart Disease

15
Pipeline Programs
23
Companies
36
Clinical Trials
1 recruiting
1
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
3
2
3
0
1
6
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
1100%
+ 40 programs with unclassified modality

On Market (1)

Approved therapies currently available

Astellas
LEXISCANApproved
regadenoson
Astellas
Adenosine Receptor Agonist [EPC]intravenous2008

Competitive Landscape

22 companies ranked by most advanced pipeline stage

Medtronic
MedtronicNJ - Phillipsburg
8 programs
1
1
StentPhase 41 trial
Resolute Integrity™ Zotarolimus-Eluting Coronary Stent SystemPhase 31 trial
Drug eluting stent treatmentN/A1 trial
RESOLUTE China Registry:N/A1 trial
Resolute Integrity™ Zotarolimus-Eluting Coronary Stent SystemN/A1 trial
+3 more programs
Active Trials
NCT01132456Completed312Est. Apr 2016
NCT01243749Completed1,800Est. Dec 2017
NCT03118531Completed40Est. Apr 2023
+5 more trials
Astellas
AstellasChina - Shenyang
3 programs
1
1
RegadenosonPhase 41 trial
RegadenosonPhase 11 trial
Using Duke Activity Status Index (DASI) to Select Optimal Cardiac Stress TestsN/A1 trial
Active Trials
NCT00907855Completed200
NCT00881218Completed50Est. Dec 2011
NCT01779869Completed16Est. Jun 2015
Pfizer
PfizerNEW YORK, NY
2 programs
2
EplerenonePhase 41 trial
celecoxibPhase 4Small Molecule1 trial
Active Trials
NCT00187889Completed70Est. Dec 2011
NCT00565500Completed24Est. Apr 2005
Medinol
MedinolIsrael - Tel Aviv
1 program
1
Catheterization, stent deploymentPhase 41 trial
Active Trials
NCT00840775Completed278Est. Jun 2011
Kite Pharma
Kite PharmaCA - El Segundo
2 programs
1
1
GS-6615Phase 21 trial
GS-6615Phase 11 trial
Active Trials
NCT01847391Completed36Est. Nov 2013
NCT02377336Withdrawn0Est. Aug 2016
Helixmith
HelixmithKorea - Seoul
2 programs
1
1
Stage 1-Low dose VM202RYPhase 21 trial
VM202-0.5 mgPhase 1/21 trial
Active Trials
NCT01422772Completed9Est. Aug 2014
NCT03404024Withdrawn0Est. Aug 2019
Innovation Pharmaceuticals
1 program
1
Standard Western medicine treatment + Chaigui Longmu Ejiao PastePhase 21 trial
Active Trials
NCT07478328Not Yet Recruiting60Est. Dec 2028
Cook MyoSite
Cook MyoSitePA - Pittsburgh
1 program
1
AMDCPhase 1/21 trial
Active Trials
NCT01353690Terminated9Est. Jun 2014
Fortis Therapeutics
Fortis TherapeuticsCA - La Jolla
1 program
1
Passive Leg RaisingPhase 11 trial
Active Trials
NCT02292888Unknown50
Abbott
AbbottABBOTT PARK, IL
8 programs
ABSORB GT1 BVSN/A1 trial
Absorb BVSN/A1 trial
Angiographic Guided PCIN/A1 trial
ICD ImplantationN/A1 trial
MINI TREK RX 1.20 mm Coronary Dilatation CatheterN/A1 trial
+3 more programs
Active Trials
NCT03409731Completed135Est. Feb 2023
NCT02943616Withdrawn0Est. Jan 2021
NCT07422688Enrolling By Invitation3,000Est. Sep 2039
+5 more trials
Terumo Medical
Terumo MedicalGermany - Leverkusen
1 program
BioMimeTM Stent, Ultimaster® StentN/A
Meril
MerilIndia - Vapi
1 program
BioMimeTM Stent, Ultimaster® StentN/A1 trial
Active Trials
NCT02986295Unknown2,000Est. Jan 2021
Precision BioSciences
1 program
Laboratory Biomarker AnalysisN/A
Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
1 program
Laboratory Biomarker AnalysisN/A1 trial
Active Trials
NCT03064360Completed200Est. Jan 2020
InspireMD
InspireMDIsrael - Tel Aviv
1 program
MGuard Coronary Stent systemN/A1 trial
Active Trials
NCT00922337Completed86Est. Dec 2013
Biotronik
BiotronikGermany - Berlin
1 program
Orsiro Sirolimus Eluting Coronary Stent SystemN/A1 trial
Active Trials
NCT03600961Terminated173Est. Dec 2021
Jubilant Therapeutics
1 program
Rb-82 RadioisotopeN/A1 trial
Active Trials
NCT05037799Unknown48Est. Apr 2025
Boston Scientific
Boston ScientificCA - Valencia
1 program
SYNERGY 48 mmN/A1 trial
Active Trials
NCT03401216Unknown80Est. Apr 2019
Cordis
CordisFL - Miami Lakes
1 program
kissing balloon inflationN/A
Philips
PhilipsNetherlands - Amsterdam
1 program
roadmapN/A1 trial
Active Trials
NCT05682118Recruiting226Est. Nov 2026
Gilead Sciences
Gilead SciencesFOSTER CITY, CA
1 program
GS-6615PHASE_1
Rhythm Pharmaceuticals
1 program
StentPHASE_4

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
AstellasRegadenoson
MedinolCatheterization, stent deployment
MedtronicStent
PfizerEplerenone
Pfizercelecoxib
MedtronicResolute Integrity™ Zotarolimus-Eluting Coronary Stent System
Innovation PharmaceuticalsStandard Western medicine treatment + Chaigui Longmu Ejiao Paste
HelixmithStage 1-Low dose VM202RY
Kite PharmaGS-6615
Cook MyoSiteAMDC
HelixmithVM202-0.5 mg
Fortis TherapeuticsPassive Leg Raising
Kite PharmaGS-6615
AstellasRegadenoson
AbbottAngiographic Guided PCI

Showing 15 of 36 trials with date data

Clinical Trials (36)

Total enrollment: 20,190 patients across 36 trials

Development of a PET-MR Myocardial Perfusion Examination Using Regadenoson

Start: Jan 2013Est. completion: Jun 201516 patients
Phase 4Completed
NCT00840775MedinolCatheterization, stent deployment

PIONIR Study (Presillion™ and Presillion™ Plus Stent Systems)

Start: Apr 2009Est. completion: Jun 2011278 patients
Phase 4Completed

Randomized Study Comparing Endeavor With Cypher Stents (PROTECT)

Start: Jun 2007Est. completion: Jul 20148,709 patients
Phase 4Completed

EWISE: Study of Eplerenone in Women With Chest Pain, Coronary Vascular Dysfunction and Evidence of Myocardial Ischemia

Start: Aug 2004Est. completion: Dec 201170 patients
Phase 4Completed

Celecoxib, Ibuprofen and the Antiplatelet Effect of Aspirin

Start: Apr 2003Est. completion: Apr 200524 patients
Phase 4Completed
NCT02452736MedtronicResolute Integrity™ Zotarolimus-Eluting Coronary Stent System

Acute Safety, Deliverability and Efficacy of the Medtronic Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System in the Treatment of Suitable Patients According to Indication for Use (CHINA RESOLUTE INTEGRITY STUDY)

Start: May 2015Est. completion: Dec 2015205 patients
Phase 3Completed
NCT07478328Innovation PharmaceuticalsStandard Western medicine treatment + Chaigui Longmu Ejiao Paste

Chaigui Longmu Ejiao Paste for Ischemic Heart Disease

Start: Mar 2026Est. completion: Dec 202860 patients
Phase 2Not Yet Recruiting
NCT03404024HelixmithStage 1-Low dose VM202RY

Safety and Efficacy Study of Gene Therapy for Acute Myocardial Infarction in Korea

Start: Jan 2018Est. completion: Aug 20190
Phase 2Withdrawn

GS-6615 in Adults With Chronic Stable Angina and Coronary Artery Disease

Start: May 2015Est. completion: Aug 20160
Phase 2Withdrawn

Autologous Cell Therapy for Ischemic Heart Failure

Start: Feb 2011Est. completion: Jun 20149 patients
Phase 1/2Terminated

Safety Study of Gene Therapy for Ischemic Heart Disease in Korea

Start: Jan 2007Est. completion: Aug 20149 patients
Phase 1/2Completed

Can Changes in Velocity Time Integral Serve as a Sensitive Indicator for Monitoring Changes in Stroke Volume ?

Start: Dec 201450 patients
Phase 1Unknown

A Phase 1 Study to Assess the Safety,Tolerability, and Pharmacokinetics of GS-6615 in Healthy Subjects

Start: May 2013Est. completion: Nov 201336 patients
Phase 1Completed

Myocardial Perfusion Magnetic Resonance Imaging Using Regadenoson

Start: Jun 2009Est. completion: Dec 201150 patients
Phase 1Completed
NCT07422688AbbottAngiographic Guided PCI

Optical Coherence Tomography in Acute Vessel Evaluation

Start: Nov 2025Est. completion: Sep 20393,000 patients
N/AEnrolling By Invitation

Impact of Dynamic CoROnary RoADmap System for Guidance of Instantaneous Wave-Free Ratio or Fractional Flow Reserve

Start: Jul 2023Est. completion: Nov 2026226 patients
N/ARecruiting

Dose Optimization for Rubidium PET Imaging in Patients With Known or Suspected Ischemic Heart Disease

Start: Jul 2022Est. completion: Apr 202548 patients
N/AUnknown
NCT03600961BiotronikOrsiro Sirolimus Eluting Coronary Stent System

BIOFLOW-SV Portugal Registry

Start: Jul 2018Est. completion: Dec 2021173 patients
N/ATerminated
NCT03466151MedtronicResolute Onyx™ Zotarolimus-Eluting Coronary Stent System

RESOLUTE ONYX China RCT Study

Start: Apr 2018Est. completion: Jul 2026550 patients
N/AActive Not Recruiting
NCT03471845MedtronicResolute Onyx™ Zotarolimus-Eluting Coronary Stent System

RESOLUTE ONYX China Single Arm Study

Start: Mar 2018Est. completion: Aug 2026591 patients
N/AActive Not Recruiting

ABSORB Post-Approval Clinical Study

Start: Aug 2017Est. completion: Jan 20210
N/AWithdrawn
NCT03118531MedtronicResolute Integrity™ Zotarolimus-Eluting Coronary Stent System

China Resolute Integrity 34/38 mm Study

Start: Apr 2017Est. completion: Apr 202340 patients
N/ACompleted

StEnt Coverage and Neointimal Tissue Characterization After eXtra Long evErolimus - Eluting Stent imPlantation

Start: Mar 2017Est. completion: Apr 201980 patients
N/AUnknown
NCT03064360Angeles TherapeuticsLaboratory Biomarker Analysis

Early Prediction of Major Adverse Cardiovascular Events Using Remote Monitoring

Start: Feb 2017Est. completion: Jan 2020200 patients
N/ACompleted
NCT03409731AbbottABSORB GT1 BVS

Absorb GT1 Japan PMS

Start: Dec 2016Est. completion: Feb 2023135 patients
N/ACompleted
NCT02986295MerilBioMimeTM Stent, Ultimaster® Stent

Registry in Korea: BioMimeTM Stent, Ultimaster® Stent vs. Xience® Stent

Start: Apr 2016Est. completion: Jan 20212,000 patients
N/AUnknown
NCT02513732AbbottXIENCE Xpedition 2.25 mm stent

XIENCE Xpedition Everolimus-Eluting Coronary Stent Japan Post Marketing Surveillance (XIENCE Xpedition SV Japan PMS)

Start: Jul 2014Est. completion: Sep 2020100 patients
N/ACompleted
NCT02513719AbbottXIENCE PRIME SV Everolimus Eluting Coronary Stent

XIENCE PRIME SV Everolimus Eluting Coronary Stent Japan Post Marketing Surveillance (XIENCE PRIME SV Japan PMS)

Start: May 2013Est. completion: Sep 2019312 patients
N/ACompleted
NCT01334268MedtronicTaxus Liberte Paclitaxel-Eluting Coronary Stent System

RESOLUTE China RCT

Start: Sep 2011Est. completion: Jun 2017400 patients
N/ACompleted
NCT01243749MedtronicRESOLUTE China Registry:

RESOLUTE China Registry:

Start: Dec 2010Est. completion: Dec 20171,800 patients
N/ACompleted
NCT01186198AbbottMINI TREK RX 1.20 mm Coronary Dilatation Catheter

A Clinical Evaluation of the MINI TREK RX 1.20 mm Coronary Dilatation Catheter in Stenotic Lesions

Start: Aug 2010Est. completion: Dec 201071 patients
N/ACompleted
NCT01266239Abbottkissing balloon inflation

Comparison Between Everolimus-eluting Stent (EES) and Sirolimus-eluting Stent (SES) in the Bifurcation Lesion

Start: Jul 2010Est. completion: Jul 2015300 patients
N/AUnknown
NCT01132456MedtronicDrug eluting stent treatment

RESOLUTE Asia: Evaluation of the Endeavor Resolute Zotarolimus-Eluting Stent System in a Patient Population With Long Lesion(s) and/or Dual Vessels in Asia

Start: Jun 2010Est. completion: Apr 2016312 patients
N/ACompleted
NCT00949000AbbottICD Implantation

AnalyST Treadmill Study

Start: Jul 2009Est. completion: Feb 201150 patients
N/ACompleted
NCT00922337InspireMDMGuard Coronary Stent system

The Israeli MGuard Registry

Start: Jul 2009Est. completion: Dec 201386 patients
N/ACompleted
NCT00907855AstellasUsing Duke Activity Status Index (DASI) to Select Optimal Cardiac Stress Tests

Using Duke Activity Status Index (DASI) to Select Optimal Cardiac Stress Tests

Start: Apr 2009200 patients
N/ACompleted

Related Jobs

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 late-stage (Phase 3) programs, potential near-term approvals
1 actively recruiting trials targeting 20,190 patients
23 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.